Literature DB >> 15776378

Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications of coinfection for excretion of eggs.

Per Kallestrup1, Rutendo Zinyama, Exnevia Gomo, Anthony E Butterworth, Govert J van Dam, Christian Erikstrup, Henrik Ullum.   

Abstract

BACKGROUND: Stunted development and reduced fecundity of Schistosoma parasites in immunodeficient mice and the impaired ability of human immunodeficiency virus 1 (HIV-1)-infected humans to excrete schistosome eggs have been described. This study explores the effect that HIV-1-associated immunodeficiency has on the excretion of schistosome eggs in a large cohort of coinfected individuals.
METHODS: In a cross-sectional survey, urine and stool samples were obtained from and HIV-1 status was determined for 1545 individuals. More extensive data, including quantitative measures of intensity of infection in schistosomiasis and immunodeficiency, were collected in the Mupfure schistosomiasis and HIV longitudinal cohort, composed of 379 participants of whom 154 were coinfected with HIV-1 and Schistosoma parasites.
RESULTS: In the cross-sectional survey, the overall prevalence of schistosomiasis was 43.4%, and 26.3% of the participants were infected with HIV-1. Schistosome infections were due to Schistosoma haematobium in 63.6% of cases, S. mansoni in 18.1% of cases, and dual infections in 18.4% of cases. Intensities of Schistosoma infections, measured by the number of eggs excreted and by the level of circulating anodic antigens, did not differ between HIV-1-negative and HIV-1-positive participants coinfected with S. haematobium, S. mansoni, or both. CD4 cell counts were significantly lower in HIV-1-positive participants and in S. mansoni-infected HIV-1-negative participants than in other participants.
CONCLUSION: The present study suggests that adult HIV-1-related immunodeficiency does not impair the ability to excrete eggs in low-intensity infection with S. haematobium, S. mansoni, or both and that infection with HIV-1 may not have major implications for diagnosis and surveillance of schistosomiasis.

Entities:  

Mesh:

Year:  2005        PMID: 15776378     DOI: 10.1086/428907

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  Decreased Sensitivity of Schistosoma sp. Egg Microscopy in Women and HIV-Infected Individuals.

Authors:  Soledad Colombe; Myung Hee Lee; Peter J Masikini; Lisette van Lieshout; Claudia J de Dood; Pytsje T Hoekstra; Paul L A M Corstjens; Julius Mngara; Govert J van Dam; Jennifer A Downs
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

2.  IL-4 and IFN-γ induced by human immunodeficiency virus vaccine in a schistosome infection model.

Authors:  Jiangmei Yin; Anlan Dai; Tatiana Arango; Ravi S Kasinathan; Robert M Greenberg; Jean D Boyer
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

3.  Proportion of Urinary Schistosomiasis among HIV-Infected Subjects in Benin City, Nigeria.

Authors:  Akinbo Frederick Olusegun; Okaka Christopher Ehis; Omoregie Richard
Journal:  Oman Med J       Date:  2011-05

4.  Association of Schistosomiasis and HIV infection in Tanzania.

Authors:  Jennifer A Downs; Govert J van Dam; John M Changalucha; Paul L A M Corstjens; Robert N Peck; Claudia J de Dood; Heejung Bang; Aura Andreasen; Samuel E Kalluvya; Lisette van Lieshout; Warren D Johnson; Daniel W Fitzgerald
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

Review 5.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

6.  Association between CD4+ T-lymphocyte counts and fecal excretion of Schistosoma mansoni eggs in patients coinfected with S. mansoni and human immunodeficiency virus before and after initiation of antiretroviral therapy.

Authors:  Erick M O Muok; Elses W Simiyu; Elizabeth A Ochola; Zipporah W Ng'ang'a; W Evan Secor; Diana M S Karanja; Pauline N M Mwinzi
Journal:  Am J Trop Med Hyg       Date:  2013-05-13       Impact factor: 2.345

7.  HIV-1 Disease Progression and Survival in an Adult Population in Zimbabwe: Is There an Effect of the Mannose Binding Lectin Deficiency?

Authors:  Rutendo B L Zinyama-Gutsire; Charles Chasela; Per Kallestrup; Simbarashe Rusakaniko; Michael Christiansen; Bernard Ngara; Exnevia Gomo; Henrik Ullum; Christian Erikstrup; Hans O Madsen; Babill Stray-Pedersen; Peter Garred; Takafira Mduluza
Journal:  OMICS       Date:  2015-09

8.  Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection.

Authors:  Martin R Jakobsen; Kieran Cashin; Michael Roche; Jasminka Sterjovski; Anne Ellett; Katharina Borm; Jacqueline Flynn; Christian Erikstrup; Maelenn Gouillou; Lachlan R Gray; Nitin K Saksena; Bin Wang; Damian F J Purcell; Per Kallestrup; Rutendo Zinyama-Gutsire; Exnevia Gomo; Henrik Ullum; Lars Ostergaard; Benhur Lee; Paul A Ramsland; Melissa J Churchill; Paul R Gorry
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

9.  Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.

Authors:  Rbl Zinyama-Gutsire; E Gomo; P Kallestrup; C Erikstrup; H Ullum; A E Butterworth; S Munyati; T Mduluza
Journal:  BMC Infect Dis       Date:  2009-10-23       Impact factor: 3.090

10.  Contribution of Schistosoma mansoni to systemic inflammation and microbial translocation among people with HIV in Zambia.

Authors:  Briana D Furch; Simutanyi Mwakamui; Sandie Sianongo; Kanekwa Zyambo; Douglas C Heimburger; John R Koethe; Paul Kelly
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-02-01       Impact factor: 2.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.